Table 1 List of potential outcomes
Categories | Outcomes |
|---|---|
Common signs and symptoms | Harris Hip Score (HHS) |
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) | |
Visual analogue scale (VAS) | |
Charnley score | |
Merle D’Aubigne score | |
Japanese Orthopedic Association Score (JOA) | |
Method used to determine the percentage of adult ONFH | |
Syndrome integral to TCM | |
Clinical effective rate | |
ROM of flexion | |
Walking distance | |
Degree of claudication | |
Quality of life | MOS Short-Form Health Survey (SF-36) |
12-item Short-Form Health Survey (SF-12) | |
Quality of Life Brief Scale (QOL-BREF) | |
EORTC-30 Scale | |
Barthel index | |
Long-term outcomes | Femoral head survival time |
Hip joint arthroplasty rate | |
Femoral head collapse rate | |
Femoral head survival rate | |
Radiological evaluation | Degree of X-ray change |
Degree of computed tomography (CT) change | |
Degree of bone marrow edema | |
Percentage of empty lacunae | |
Sample line of magnetic resonance imaging (MRI) | |
Necrotic bone resorption rate | |
New bone repair rate | |
Bone mineral density | |
Blood biochemistry | Erythrocyte sedimentation rate (ESR) |
Lipid indexes | |
Bone Gla protein (BGP) | |
Endothelin (ET) | |
Bone morphogenetic protein 2 (BMP2) | |
Osteoblasts (OB) | |
Osteoclasts (OC) | |
Osteoprotegerin (OPG) | |
Alkaline phosphatase (ALP) | |
C-reactive protein (CRP) | |
Indexes of safety | Adverse effect rate |
Adverse events | |
Detection of blood biochemical indexes |